Ladjemi MZ, Jacot W, Chardès T, Pèlegrin A, Navarro-Teulon I. Anti-HER2 vaccines: new prospects for breast cancer therapy. Cancer Immunol Immunother. 2010;59(9):1295–312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ross JS. Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy. Drug News Perspect. 2009;22(2):93–106.

Article  CAS  PubMed  Google Scholar 

Phillips GDL, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, et al. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody–cytotoxic drug conjugate. Cancer Res. 2008;68(22):9280–90.

Article  Google Scholar 

Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JM, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update. Arch Pathol Lab Med. 2018;142(11):1364–82.

Article  PubMed  Google Scholar 

Foukakis T, Åström G, Lindström L, Hatschek T, Bergh J. When to order a biopsy to characterise a metastatic relapse in breast cancer. Ann Oncol. 2012;23:349–53.

Article  Google Scholar 

Houssami N, Macaskill P, Balleine RL, Bilous M, Pegram MD. HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis. Breast Cancer Res Treat. 2011;129(3):659–74.

Article  CAS  PubMed  Google Scholar 

Wilking U, Karlsson E, Skoog L, Hatschek T, Lidbrink E, Elmberger G, et al. HER2 status in a population-derived breast cancer cohort: discordances during tumor progression. Breast Cancer Res Treat. 2011;125(2):553–61.

Article  CAS  PubMed  Google Scholar 

Mathenge EG, Dean CA, Clements D, Vaghar-Kashani A, Photopoulos S, Coyle KM, et al. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Neoplasia. 2014;16(11):950–60.

Article  PubMed  PubMed Central  Google Scholar 

Tolmachev V, Orlova A, Sörensen J. The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer. Semin Cancer Biol. 2021. https://doi.org/10.1016/j.semcancer.2020.10.005.

Article  PubMed  Google Scholar 

Gebhart G, Lamberts L, Wimana Z, Garcia C, Emonts P, Ameye L, et al. Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. Ann Oncol. 2016;27(4):619–24.

Article  CAS  PubMed  Google Scholar 

Behr T, Behe M, Wörmann B. Trastuzumab and breast cancer. N Engl J Med. 2001;345(13):995–6.

Article  CAS  PubMed  Google Scholar 

Dijkers E, Oude Munnink T, Kosterink J, Brouwers A, Jager P, De Jong J, et al. Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther. 2010;87(5):586–92.

Article  CAS  PubMed  Google Scholar 

Mortimer JE, Shively JE. Functional imaging of human epidermal growth factor receptor 2–positive breast cancers and a note about NOTA. J Nucl Med. 2019;60(1):23–5.

Article  CAS  PubMed  Google Scholar 

Perik PJ, Lub-De Hooge MN, Gietema JA, Van der Graaf W, de Korte MA, Jonkman S, et al. Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 2006;24(15):2276–82.

Article  CAS  PubMed  Google Scholar 

Sörensen J, Sandberg D, Sandström M, Wennborg A, Feldwisch J, Tolmachev V, et al. First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule. J Nucl Med. 2014;55(5):730–5.

Article  PubMed  Google Scholar 

Zahnd C, Kawe M, Stumpp MT, de Pasquale C, Tamaskovic R, Nagy-Davidescu G, et al. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. Cancer Res. 2010;70(4):1595–605.

Article  CAS  PubMed  Google Scholar 

van Scheltinga AGT, Lub-de Hooge MN, Hinner MJ, Verheijen RB, Allersdorfer A, Hülsmeyer M, et al. In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer. J Nucl Med. 2014;55(4):665–71.

Article  Google Scholar 

Hackel BJ, Kimura RH, Gambhir SS. Use of 64Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging. Radiology. 2012;263(1):179–88.

Article  PubMed  PubMed Central  Google Scholar 

Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Höidén-Guthenberg I, et al. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Can Res. 2006;66(8):4339–48.

Article  CAS  Google Scholar 

Jiang L, Tu Y, Kimura RH, Habte F, Chen H, Cheng K, et al. 64Cu-labeled divalent cystine knot peptide for imaging carotid atherosclerotic plaques. J Nucl Med. 2015;56(6):939–44.

Article  CAS  PubMed  Google Scholar 

Goldstein R, Sosabowski J, Livanos M, Leyton J, Vigor K, Bhavsar G, et al. Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging. Eur J Nucl Med Mol Imaging. 2015;42(2):288–301.

Article  CAS  PubMed  Google Scholar 

Krasniqi A, D’Huyvetter M, Devoogdt N, Frejd FY, Sörensen J, Orlova A, et al. Same-day imaging using small proteins: clinical experience and translational prospects in oncology. J Nucl Med. 2018;59(6):885–91.

Article  CAS  PubMed  Google Scholar 

Boersma YL, Plückthun A. DARPins and other repeat protein scaffolds: advances in engineering and applications. Curr Opin Biotechnol. 2011;22(6):849–57.

Article  CAS  PubMed  Google Scholar 

Vorobyeva A, Schulga A, Konovalova E, Güler R, Mitran B, Garousi J, et al. Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2. Int J Oncol. 2019;54(4):1209–20.

CAS  PubMed  PubMed Central  Google Scholar 

Zahnd C, Pecorari F, Straumann N, Wyler E, Plückthun A. Selection and characterization of Her2 binding-designed ankyrin repeat proteins. J Biol Chem. 2006;281(46):35167–75.

Article  CAS  PubMed  Google Scholar 

Steiner D, Forrer P, Plückthun A. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J Mol Biol. 2008;382(5):1211–27.

Article  CAS  PubMed  Google Scholar 

Houlihan G, Gatti-Lafranconi P, Lowe D, Hollfelder F. Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process. Protein Eng Des Sel. 2015;28(9):269–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Yu X, Song X, Liu L, Yi Y, Yao W, et al. Selection, purification, and characterization of a HER2-targeting soluble designed ankyrin repeat protein by E. coli surface display using HER2-positive melanoma cells. Prep Biochem Biotechnol. 2018;48(2):144–50.

Article  CAS  PubMed  Google Scholar 

Binz HK, Stumpp MT, Forrer P, Amstutz P, Plückthun A. Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol. 2003;332(2):489–503.

Article  CAS  PubMed  Google Scholar 

Hausammann S, Vogel M, Kremer Hovinga JA, Lacroix-Desmazes S, Stadler BM, Horn MP. Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes? PLoS ONE. 2013;8(4):60688.

Article  Google Scholar 

Bragina O, Chernov V, Schulga A, Konovalova E, Garbukov E, Vorobyeva A, et al. Phase I trial of 99mTc-(HE) 3–G3, a DARPin-based probe for imaging of HER2 expression in breast cancer. J Nucl Med. 2022;63(4):528–35.

Article  PubMed  PubMed Central  Google Scholar 

Jost C, Schilling J, Tamaskovic R, Schwill M, Honegger A, Plückthun A. Structural basis for eliciting a cytotoxic effect in HER2-overexpressing cancer cells via binding to the extracellular domain of HER2. Structure. 2013;21(11):1979–91.

Article  CAS  PubMed  Google Scholar 

Zahnd C, Amstutz P, Plückthun A. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat Methods. 2007;4(3):269–79.

Article  CAS  PubMed  Google Scholar 

Vieira Gomes AM, Souza Carmo T, Silva Carvalho L, Mendonça Bahia F, Parachin NS. Comparison of yeasts as hosts for recombinant protein production. Microorganisms. 2018;6(2):38.

Article  PubMed Central  Google Scholar 

Shanmugaraj B, Bulaon I, CJ, Phoolcharoen W,. Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants. 2020;9(7):842.

Article  CAS  PubMed Central  Google Scholar 

Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J. 2010;8(5):620–37.

Article  CAS  PubMed  PubMed Central  Google Scholar